Publicaciones en las que colabora con Eladio Rafael Vázquez Gallardo (7)

2016

  1. HLA-DQ B1*0201 and A1*0102 alleles are not responsible for antituberculosis drug-induced hepatotoxicity risk in Spanish population

    Frontiers in Medicine, Vol. 3, Núm. AUG

2011

  1. N-acetyltransferase 2 polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity in Caucasians

    International Journal of Tuberculosis and Lung Disease, Vol. 15, Núm. 10, pp. 1403-1408

2010

  1. Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population.

    Pharmacogenomics

2008

  1. Factores predictores de la aparición de nuevos casos de infección tuberculosa y de viraje tuberculínico en un estudio de contactos

    Enfermería clínica, Vol. 18, Núm. 4, pp. 183-189

2007

  1. Multidrug-resistant tuberculosis in a low-incidence region shows a high rate of transmission

    International Journal of Tuberculosis and Lung Disease, Vol. 11, Núm. 4, pp. 429-435

2005

  1. Study of Mycobacterium tuberculosis drug resistance in the region of Galicia, Spain

    International Journal of Tuberculosis and Lung Disease, Vol. 9, Núm. 11, pp. 1230-1235

2004

  1. The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity

    International Journal of Tuberculosis and Lung Disease, Vol. 8, Núm. 12, pp. 1499-1505